In just one week, Secaucus-based Quest Diagnostics announced two new product offerings: one for at-home consumer use and another for physicians. The consumer product, Genetic Insights, helps people ...

Quest Diagnostics DGX recently launched a novel prostate cancer biomarker test through its subspecialty pathology business unit, AmeriPath. The laboratory test is developed in collaboration with ...

Quest’s two AD-Detect blood-based tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer’s disease pathology in ...

Two blood tests, each involving multiple biomarkers, are highly accurate at identifying Alzheimer's disease pathology in symptomatic patients, supporting diagnosis, according to a new study in ...

Quest Diagnostics announced a new antibody test service — based on the Zika immunoglobulin M antibody capture enzyme-linked immunosorbent assay developed by the CDC — is available for the detection of ...

Quest Diagnostics Incorporated DGX recently announced that the company is now offering the liquid biopsy-based Target Selector NGS Lung Panel test developed by Biocept BIOC. The addition of this blood ...

Quest Diagnostics has launched an at-home diagnostic test for COVID-19 that individuals can order online, but the out-of-pocket cost for the test could get in the way of widespread use. The test, ...

In 2004, Quest Diagnostics co-exclusively licensed certain ion mobility patents for lipoprotein analysis from Ernest Orlando Lawrence Berkeley National Laboratory ("Berkeley Lab") in Berkeley, CA, and ...

May enhance evaluation of cancer risk in the up to 1.5 million women who receive an indeterminate Pap test result each year MADISON, N.J., Aug. 30, 2012 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), ...

Quest Diagnostics is warning of delays in getting COVID-19 test results due to soaring consumer demand. The average turnaround time is now seven days, compared with two to three days in early June, ...

The private testing lab is ramping up tests at the behest of the government. In the two weeks since Quest Diagnostics began processing novel coronavirus samples in its infectious disease lab, the ...